Detalhe da pesquisa
1.
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
HIV Med
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689512
2.
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial.
Clin Infect Dis
; 76(4): 720-729, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235656
3.
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study.
Clin Infect Dis
; 77(4): 593-605, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052343
4.
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
HIV Med
; 24(9): 965-978, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990962
5.
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.
J Antimicrob Chemother
; 77(6): 1738-1740, 2022 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274144
6.
Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens.
J Antimicrob Chemother
; 78(1): 108-116, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36308326
7.
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study.
J Antimicrob Chemother
; 77(8): 2265-2273, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678461
8.
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
HIV Med
; 23(8): 825-836, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234328
9.
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
HIV Med
; 23(6): 585-598, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889022
10.
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series.
AIDS Res Ther
; 19(1): 6, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35148782
11.
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019.
Clin Infect Dis
; 73(7): e1964-e1972, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32905581
12.
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
Clin Infect Dis
; 73(7): e2323-e2333, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33354721
13.
Redefining therapeutic success in HIV patients: an expert view.
J Antimicrob Chemother
; 76(10): 2501-2518, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077524
14.
Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review.
BMC Public Health
; 21(1): 1596, 2021 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34454444
15.
Routine Screening of Anal Cytology in Persons With Human Immunodeficiency Virus and the Impact on Invasive Anal Cancer: A Prospective Cohort Study.
Clin Infect Dis
; 71(2): 390-399, 2020 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504329
16.
Prevention of Anal Cancer.
N Engl J Med
; 387(7): 666, 2022 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070726
17.
High-level dolutegravir resistance selection on dolutegravir/lamivudine.
Clin Infect Dis
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462967
18.
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
Lancet
; 391(10123): 839-849, 2018 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310899
19.
Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide.
Infection
; 47(1): 115-119, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145772
20.
Prescription of antimicrobials in primary health care as a marker to identify people living with undiagnosed HIV infection, Denmark, 1998 to 2016.
Euro Surveill
; 24(41)2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615598